Trial Profile
A Randomized Controlled Trial Evaluating the Use of G-CSF After Plerixafor-Mobilized Autologous Stem Cell Transplant (Auto HSCT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2022
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- 16 Nov 2022 Status changed from active, no longer recruiting to completed.
- 31 Aug 2021 Status changed from recruiting to active, no longer recruiting.
- 08 Nov 2017 Status changed from not yet recruiting to recruiting.